+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Oral Mucositis - Pipeline Insight, 2024 - Product Thumbnail Image

Oral Mucositis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Pancreatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gastroparesis - Pipeline Insight, 2024 - Product Thumbnail Image

Gastroparesis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Peptic Ulcer - Pipeline Insight, 2024 - Product Thumbnail Image

Peptic Ulcer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Anal Fissure - Pipeline Insight, 2024 - Product Thumbnail Image

Anal Fissure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gastric Ulcers - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Ulcers - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Fecal Incontinence - Pipeline Insight, 2024 - Product Thumbnail Image

Fecal Incontinence - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Eosinophilic Esophagitis - Pipeline Insight, 2024 - Product Thumbnail Image

Eosinophilic Esophagitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Duodenal Ulcer - Pipeline Insight, 2024 - Product Thumbnail Image

Duodenal Ulcer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Diabetic Gastroparesis - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Gastroparesis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Emesis - Pipeline Insight, 2024 - Product Thumbnail Image

Emesis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 65 Pages
  • Global
From
Lipodystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Norovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Norovirus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic pancreatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic pancreatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Rotavirus infections - Pipeline Insight, 2024 - Product Thumbnail Image

Rotavirus infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Erosive Esophagitis - Pipeline Insight, 2024 - Product Thumbnail Image

Erosive Esophagitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Diverticulitis - Pipeline Insight, 2024 - Product Thumbnail Image

Diverticulitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Complicated Intra-Abdominal Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Complicated Intra-Abdominal Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Mallory-weiss Tear - Pipeline Insight, 2024 - Product Thumbnail Image

Mallory-weiss Tear - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Biliary Atresia - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Atresia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more